Search is Powered by Google
Prostate / Prostate Cancer News

Testosterone Administration To Men With Testosterone Deficiency Syndrome After External Beam Radiotherapy For Localized Prostate Cancer

Main Category: Prostate / Prostate Cancer
Also Included In: Urology / Nephrology;  Cancer / Oncology
Article Date: 05 Sep 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

UroToday.com - Dr. Alvaro Morales and associates from the Centre for Applied Urological Research, reported on the first study on testosterone deficiency syndrome (TDS) in men treated with radiotherapy for prostate cancer. Five men with clinically localized CaP were prospectively studied. The mean Gleason sum was 7 and mean PSA level before radiotherapy was 12.8ng/ml. The mean PSA before testosterone replacement therapy (TRT) was 0.3ng/ml.

All five men had symptoms of TDS and two chose intramuscular injections of testosterone, one oral replacement and two used transdermal patches. Testosterone levels before TRT were 5.3 and at last visit were 17.6. The duration of follow-up was 14.6 months. One man had a transitory PSA increase, but none had levels of >1.5ng/ml.

All patients had marked responses in the symptoms of TDS, four with decreased hot flashes, decreased fatigue and improved libido, and two reported improved erectile function. One man discontinued therapy due to headaches. Four men had an improvement in sexual interest, but none recovered satisfactory erectile function with testosterone alone. A phosphodiesterase-5 inhibitor was successful in three men. The best overall symptom improvements were in hot flashes and fatigue. This report is hypothesis-generating for larger studies to address this issue.

Morales A, Black AM, Emerson LE
BJU Int. 2008 Jul 29. Epub ahead of print.
doi:10.1111/j.1464-410X.2008.07882.x

Reported by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.

To access the latest urology news releases from UroToday, go to: www.urotoday.com

Copyright © 2008 - UroToday




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Prostate Cancer Drug Breakthrough For Aggressive Form Of Disease
22 Jul 2008
A new trial drug called abiraterone has shown a high success rate at treating men with an aggressive, drug resistant, and often fatal form of prostate cancer. 70 to 80 per cent of the men on the trial experienced dramatic...


Talking with Your Doctor image Talking with Your Doctor

Talking with your doctor can sometimes be difficult. Good health care, however, depends on an open dialogue between patients and doctors...

Improving Health Care image Improving Health Care

Improvements are necessary to make sure Americans get the best quality health care and that money for this care is being spent as effectively as possible. Listen as experts -- both in government and in the private sector -- describe some of the steps taken to improve the health care system...

View more videos...